Tyrphostin RG14620 is primarily used as a selective inhibitor of receptor tyrosine kinases, particularly targeting the epidermal growth factor receptor (EGFR) pathway. It is widely applied in research settings to study signal transduction mechanisms involved in cell proliferation, differentiation, and apoptosis. Due to its ability to block tyrosine kinase activity, it serves as a valuable tool in cancer research, especially in investigating tumor growth and metastasis in models of epithelial cancers. Additionally, it has been used to explore the role of kinase signaling in inflammatory processes and neurodegenerative diseases. Its specificity makes it suitable for experiments requiring precise modulation of EGFR-mediated pathways without broad cytotoxic effects.